Filter Results
:
(234)
Show Results For
-
All HBS Web
(1,712)
- Faculty Publications (234)
Show Results For
-
All HBS Web
(1,712)
- Faculty Publications (234)
- October 2005 (Revised June 2007)
- Case
Apollo Hospitals--First-World Health Care at Emerging-Market Prices
By: Felix Oberholzer-Gee, Tarun Khanna and Carin-Isabel Knoop
The Apollo Hospitals Group, one of Asia's premier health care organizations, had come to rival the best health care organizations on the globe. Apollo offered advanced medical procedures, such as cardiac surgery using the beating heart technique, at very high levels of...
View Details
Keywords:
Vertical Integration;
Decision Choices and Conditions;
Health Care and Treatment;
Global Strategy;
Developing Countries and Economies;
Health Industry;
Thailand;
United States;
India
Oberholzer-Gee, Felix, Tarun Khanna, and Carin-Isabel Knoop. "Apollo Hospitals--First-World Health Care at Emerging-Market Prices." Harvard Business School Case 706-440, October 2005. (Revised June 2007.)
- August 2005 (Revised December 2005)
- Teaching Note
Global Healthcare Exchange (TN)
- November 2004 (Revised January 2010)
- Teaching Note
World Vision International's AIDS Initiative: Challenging a Global Partnership (TN)
Teaching Note to (9-304-105).
View Details
Keywords:
Health Disorders
- October 2004
- Case
DNA Traceability at Maple Leaf Foods
By: Ray A. Goldberg, Joan McRobbie and Matthew L. Reisman
Maple Leaf Foods is concerned about the bovine spongiform encephalopathy (Mad Cow Disease) issue in Canada and the reputation of Canadian meat products in the domestic and global markets. DNA can now trace products from sow and piglets to consumer pork products....
View Details
- July 2004
- Supplement
World Vision International: The AIDS Initiative
Management discusses the organizational and governance challenges of operating a global network of partner organizations. Then key managers reflect on the decision World Vision must make on the AIDS Hope Initiative--a new strategic direction that challenges many of the...
View Details
Keywords:
Health Care and Treatment;
Goals and Objectives;
Corporate Social Responsibility and Impact;
Problems and Challenges;
Core Relationships;
Welfare;
Value;
Health Industry
Bartlett, Christopher A. "World Vision International: The AIDS Initiative." Harvard Business School Video Supplement 305-701, July 2004.
- 2004
- Chapter
Genzyme's Gaucher Initiative: Global Risk and Responsibility
By: Christopher A. Bartlett and Andrew N. McLean
- October 2003 (Revised January 2004)
- Case
BSE in Canada
By: Ray A. Goldberg and Kevin Allison
A cow was determined to have Bovine Spongiform Encephalopathy in Canada, which closed its beef exports to the United States and 39 other countries. What future action should be taken, and how will country of origin specification and traceability take place in the...
View Details
Keywords:
Animal-Based Agribusiness;
Trade;
Food;
Globalized Markets and Industries;
Health;
Health Industry;
Health Industry;
Canada
Goldberg, Ray A., and Kevin Allison. "BSE in Canada." Harvard Business School Case 904-413, October 2003. (Revised January 2004.)
- July 2003 (Revised August 2003)
- Case
Global Healthcare Exchange
By: Lynda M. Applegate and Jamie Ladge
Founded in March 2000 at the height of the dot-com bubble, Global Healthcare Exchange (GHX) was one of 90 online marketplaces in the health care industry. The company's founders were among the largest suppliers in the industry, including Johnson & Johnson, GE Medical,...
View Details
Keywords:
Mergers and Acquisitions;
Entrepreneurship;
Price;
Leadership;
Growth and Development Strategy;
Supply and Industry;
Organizational Design;
Expansion;
Internet and the Web;
Valuation;
Health Industry
Applegate, Lynda M., and Jamie Ladge. "Global Healthcare Exchange." Harvard Business School Case 804-002, July 2003. (Revised August 2003.)
- June 2003 (Revised November 2003)
- Case
Siemens Medical Solutions: Strategic Turnaround
By: D. Quinn Mills and Julian Kurz
Describes how Siemens Medical Solutions (MED) accomplished a remarkable turnaround from a money-losing operation to one of Siemens' most profitable divisions. By late 1996, a challenging market environment in the health care industry as well as inefficiencies in the...
View Details
Keywords:
Opportunities;
Globalized Firms and Management;
Health Care and Treatment;
Transformation;
Problems and Challenges;
Medical Devices and Supplies Industry
Mills, D. Quinn, and Julian Kurz. "Siemens Medical Solutions: Strategic Turnaround." Harvard Business School Case 703-494, June 2003. (Revised November 2003.)
- June 2003 (Revised May 2006)
- Case
Cipla
By: Rohit Deshpande and Laura Winig
The head of Cipla, a $325-million-dollar Indian pharmaceutical company and seller of low-cost AIDS drugs to South Africa, must decide what to do about Cipla's future. With India poised to enforce international patents in only two years, much of Cipla's product line...
View Details
- October 2002 (Revised February 2006)
- Case
Codex Alimentarius and Food Labeling
By: Ray A. Goldberg and Hal Hogan
Codex Alimentarius is a set of international food standards devised by the Codex Commission, a body within the United Nations jointly sponsored by the FAO and WHO. The purpose of the standards is to harmonize global trade in food products and agricultural commodities,...
View Details
Keywords:
Standards;
Trade;
Agreements and Arrangements;
Food;
Agribusiness;
Governing Rules, Regulations, and Reforms;
Globalization;
Health;
Food and Beverage Industry;
Agriculture and Agribusiness Industry
Goldberg, Ray A., and Hal Hogan. "Codex Alimentarius and Food Labeling." Harvard Business School Case 903-417, October 2002. (Revised February 2006.)
- September 2002 (Revised April 2006)
- Case
Istituto Clinico Humanitas (A)
By: Richard M.J. Bohmer, Gary P. Pisano and Ning Tang
Istituto Clinico Humanitas is a newly built private hospital, south of Milan, Italy, that has attained unusual profitability while treating public system patients. The hospital was built and is managed by Techosp, a subsidiary of Techint, a global engineering and...
View Details
Keywords:
Health Care and Treatment;
Management Analysis, Tools, and Techniques;
Management Systems;
Infrastructure;
Managerial Roles;
Integration;
Performance;
Health Industry;
Milan
Bohmer, Richard M.J., Gary P. Pisano, and Ning Tang. "Istituto Clinico Humanitas (A)." Harvard Business School Case 603-063, September 2002. (Revised April 2006.)
- January 2002
- Case
Price-Fixing Vignettes
By: Guhan Subramanian and Michelle Kalka
This case escribes the antitrust prosecutions in the United States and abroad of the international bulk vitamins cartel. Both the civil and criminal fines were historically high, and it was the first time the United States prosecuted foreign nationals for U.S. criminal...
View Details
Keywords:
Price;
Lawsuits and Litigation;
Governance Compliance;
Auctions;
Laws and Statutes;
Monopoly;
Globalized Markets and Industries;
Health Industry;
Health Industry;
United States
Subramanian, Guhan, and Michelle Kalka. "Price-Fixing Vignettes." Harvard Business School Case 902-068, January 2002.
- August 2001 (Revised April 2003)
- Case
International Trachoma Initiative
By: Diana Barrett, James E. Austin and Sheila McCarthy
In an effort to combat trachoma, a major eye disease, the Clark Foundation entered into a partnership with Pfizer Pharmaceuticals. After a successful pilot project, a joint initiative was established (the Trachoma initiative) that has as its goal to eradicate the...
View Details
Keywords:
For-Profit Firms;
Joint Ventures;
Globalization;
Mission and Purpose;
Organizational Culture;
Alliances;
Partners and Partnerships;
Non-Governmental Organizations;
Health Industry
Barrett, Diana, James E. Austin, and Sheila McCarthy. "International Trachoma Initiative." Harvard Business School Case 302-009, August 2001. (Revised April 2003.)
- January 2001
- Case
Merck Global Health Initiatives (A)
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,...
View Details
Keywords:
Programs;
Philanthropy and Charitable Giving;
Health Disorders;
Health Care and Treatment;
Private Sector;
Public Sector;
Alliances;
Problems and Challenges;
Pharmaceutical Industry;
Botswana
Austin, James E., Diana Barrett, and James Weber. "Merck Global Health Initiatives (A)." Harvard Business School Case 301-088, January 2001.
- January 2001
- Case
Merck Global Health Initiatives (B): Botswana
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,...
View Details
Keywords:
Health Disorders;
Health Care and Treatment;
Private Sector;
Public Sector;
Alliances;
Problems and Challenges;
Africa;
Botswana
Austin, James E., Diana Barrett, and James Weber. "Merck Global Health Initiatives (B): Botswana." Harvard Business School Case 301-089, January 2001.
- January 2001 (Revised May 2003)
- Case
Novartis Pharma: The Business Unit Model
By: Srikant M. Datar, Carin-Isabel Knoop and Cate Reavis
In June 2000, Novartis reorganized its pharmaceutical business to form global business units in oncology, transplantation, ophthalmology, and mature products. The remaining primary care products continued to be managed within global functions (e.g., R&D and marketing)....
View Details
Keywords:
Restructuring;
Recruitment;
Product Marketing;
Organizational Structure;
Problems and Challenges;
Health Industry;
Health Industry
Datar, Srikant M., Carin-Isabel Knoop, and Cate Reavis. "Novartis Pharma: The Business Unit Model." Harvard Business School Case 101-030, January 2001. (Revised May 2003.)
- 2001
- Chapter
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While...
View Details
Keywords:
Public Sector;
Science-Based Business;
Research and Development;
Sovereign Finance;
Pharmaceutical Industry
Henderson, Rebecca, and Ian Cockburn. "Publicly Funded Science and the Productivity of the Pharmaceutical Industry." In Innovation Policy and the Economy, Volume 1, edited by Adam B. Jaffe, Josh Lerner, and Scott Stern, 1–34. MIT Press, 2001.
- October 1998 (Revised December 1999)
- Case
Gene Research, the Mapping of Life and the Global Economy
By: Ray A. Goldberg and Juan Enriquez-Cabot
A new firm is being created to speed up the process of mapping humans, animals, and plants by combining gene technology with rapid gene identification to improve the health and well being of the human population and the productivity of crops and animals. How does one...
View Details
Keywords:
Information Technology;
Organizational Structure;
Technological Innovation;
Business Processes;
Health Care and Treatment;
Performance Productivity;
Welfare;
Agribusiness;
Genetics;
Science-Based Business;
Biotechnology Industry;
Agriculture and Agribusiness Industry
Goldberg, Ray A., and Juan Enriquez-Cabot. "Gene Research, the Mapping of Life and the Global Economy." Harvard Business School Case 599-016, October 1998. (Revised December 1999.)
- September 1995
- Case
Ares-Serono
By: Michael Y. Yoshino, Jean-Pierre Jeannet and Carin-Isabel Knoop
Ares Serono, a medium-size Swiss pharmaceutical company, is the global leader in the field of fertility drugs. The company has successfully transformed into one of the very few biotech firms in Europe. The case treats a set of major strategic and organizational...
View Details
Keywords:
Geographic Location;
Globalized Firms and Management;
Asset Management;
Balance and Stability;
Expansion;
Digital Platforms;
Leadership Development;
Health Care and Treatment;
Transformation;
Family Business;
Problems and Challenges;
Pharmaceutical Industry;
Biotechnology Industry;
Switzerland;
Europe
Yoshino, Michael Y., Jean-Pierre Jeannet, and Carin-Isabel Knoop. "Ares-Serono." Harvard Business School Case 396-035, September 1995.